Ankit Dhoundiyal, Vanessa Goeschl, Stefan Boehm, Helmut Kubista, Matej Hotka
{"title":"IP<sub>3</sub>-mediated Ca<sup>2+</sup> transfer from ER to mitochondria stimulates ATP synthesis in primary hippocampal neurons.","authors":"Ankit Dhoundiyal, Vanessa Goeschl, Stefan Boehm, Helmut Kubista, Matej Hotka","doi":"10.1016/j.neuropharm.2025.110626","DOIUrl":null,"url":null,"abstract":"<p><p>During electrical activity, Ca<sup>2+</sup> enhances mitochondrial ATP production, helping to replenish the energy consumed during this process. Most Ca<sup>2+</sup> enters the cell via ligand- or voltage-gated channels on the neuronal membrane, where it stimulates the release of additional Ca<sup>2+</sup> from the endoplasmic reticulum (ER). Although the influence of cytosolic Ca<sup>2+</sup> on neuronal metabolism has been widely investigated, relatively few studies have explored the contribution of ER Ca<sup>2+</sup> release in this context. Therefore, we investigated how activity-driven Ca<sup>2+</sup> crosstalk between the ER and mitochondria influences the regulation of mitochondrial ATP production. We show that in primary hippocampal neurons derived from rat pups of either sex, depletion of ER Ca<sup>2+</sup> led to a reduction in mitochondrial Ca<sup>2+</sup> levels during both resting and stimulated states, while exerting only a minimal impact on cytosolic Ca<sup>2+</sup> levels. Additionally, impaired ER-mitochondria Ca<sup>2+</sup> transfer led to a reduction in mitochondrial ATP production. Similar effects were observed when inositol-3-phosphate receptors (IP<sub>3</sub>Rs), but not ryanodine receptors (RyRs), were pharmacologically inhibited. Together, our findings show that, in hippocampal neurons, Ca<sup>2+</sup> is transferred from the ER to mitochondria through IP<sub>3</sub> receptors, and this Ca<sup>2+</sup> crosstalk in turn enhances mitochondrial ATP production in response to neuronal activity.</p>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":" ","pages":"110626"},"PeriodicalIF":4.6000,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.neuropharm.2025.110626","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
During electrical activity, Ca2+ enhances mitochondrial ATP production, helping to replenish the energy consumed during this process. Most Ca2+ enters the cell via ligand- or voltage-gated channels on the neuronal membrane, where it stimulates the release of additional Ca2+ from the endoplasmic reticulum (ER). Although the influence of cytosolic Ca2+ on neuronal metabolism has been widely investigated, relatively few studies have explored the contribution of ER Ca2+ release in this context. Therefore, we investigated how activity-driven Ca2+ crosstalk between the ER and mitochondria influences the regulation of mitochondrial ATP production. We show that in primary hippocampal neurons derived from rat pups of either sex, depletion of ER Ca2+ led to a reduction in mitochondrial Ca2+ levels during both resting and stimulated states, while exerting only a minimal impact on cytosolic Ca2+ levels. Additionally, impaired ER-mitochondria Ca2+ transfer led to a reduction in mitochondrial ATP production. Similar effects were observed when inositol-3-phosphate receptors (IP3Rs), but not ryanodine receptors (RyRs), were pharmacologically inhibited. Together, our findings show that, in hippocampal neurons, Ca2+ is transferred from the ER to mitochondria through IP3 receptors, and this Ca2+ crosstalk in turn enhances mitochondrial ATP production in response to neuronal activity.
期刊介绍:
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).